Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

Clinical trial NCT02920996 · TERMINATED

Trial details

NCT number: NCT02920996
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Solid Tumor

Start date: 2016-11-11
Primary completion: 2021-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.